蒙古族人群中丝氨酸苏氨酸激酶39(STK39)基因多态性与环境因素交互作用对原发性高血压的影响

田英杰 ,  苏日娜 ,  赵兴胜

中华高血压杂志(中英文) ›› 2026, Vol. 34 ›› Issue (7) : 677 -684.

PDF (818KB)
中华高血压杂志(中英文) ›› 2026, Vol. 34 ›› Issue (7) : 677 -684. DOI: 10.16439/j.issn.1673-7245.2025-0304
临床经验交流

蒙古族人群中丝氨酸苏氨酸激酶39(STK39)基因多态性与环境因素交互作用对原发性高血压的影响

作者信息 +

Gene-environment interactions between serine threonine kinase 39 (STK39) polymorphisms and environmental factors on essential hypertension of Mongolians

Author information +
文章历史 +
PDF (836K)

摘要

目的 探讨丝氨酸苏氨酸激酶39(STK39)基因变异(rs35929607、rs3754777、rs6749447、rs4977950)与原发性高血压的关联,以及这些基因变异与环境因素在内蒙古人群中的交互作用。方法 本研究为人群病例对照研究,在2019—2020年纳入219例蒙古族高血压患者和161名正常血压对照者。对4个STK39单核苷酸多态性(SNP)进行基因分型,并通过广义多因素降维法(GMDR)评估SNP与生活方式(吸烟、饮酒、饮茶、盐摄入)的交互作用。结果 与正常血压对照比较,高血压患者表现出更高的体重指数[(26.45±4.18)比(23.62±3.49)kg/m2t=6.968,P<0.001]、高尿酸血症(19.2%比10.6%,χ2=5.256,P=0.022)、甘油三酯[1.57(1.18, 2.06)比1.14(0.86, 1.65)mmol/L,Z=5.210,P<0.001]以及饮茶比例(64.4%比54.0%,χ2=4.139,P=0.045)。未发现STK39基因多态性与高血压之间存在统计学关联(均P>0.05)。在交互作用分析中,GMDR模型初筛提示STK39多态性与饮茶可能存在交互信号,但经logistic回归验证,在校正混杂因素后,未发现STK39多态性与饮茶行为的交互作用具有统计学意义。结论 在蒙古族人群中,高血压发病可能与肥胖、血脂异常等因素相关,而与STK39基因多态性的相关性无统计学意义。

Abstract

Objective To examine the association between serine threonine kinase 39 (STK39) variants (rs35929607, rs3754777, rs6749447, rs4977950) and hypertension as well as their interactions with environmental factors in Mongolians. Methods A population-based case-control study was conducted from 2019 to 2020, enrolling 219 hypertensive and 161 normotensive Mongolian adults. Four STK39 tagging single nucleotide polymorphism (SNP) were genotyped by SNaPshot assay; gene-lifestyle (smoking, alcohol, tea, dietary salt) interactions were analysed with generalized multifactor dimensionality reduction (GMDR). Results Compared with normotensive individuals, patients with hypertension exhibited a significantly higher body mass index (BMI) ([26.45±4.18]vs [23.62±3.49] kg/m2, t=6.968, P<0.001), higher prevalence of hyperuricemia (19.2% vs 10.6%, χ2=5.256, P=0.022), elevated triglyceride levels (1.57 [1.18, 2.06]vs 1.14 [0.86, 1.65] mmol/L,Z=5.210, P<0.001), and higher rate of tea consumption (64.4% vs 54.0%, χ2=4.139, P=0.045). No statistically significant association was found between STK39 polymorphisms and hypertension (all P>0.05). In interaction analyses, the GMDR model suggested a potential interaction signal between STK39 polymorphisms and tea consumption. However, logistic regression validation revealed no statistically significant interaction between STK39 polymorphisms and tea-drinking behavior after adjustment for confounders. Conclusion Among the Mongolian population, hypertension onset is more prominently associated with obesity and dyslipidemia, while not associated with STK39 gene.

关键词

丝氨酸苏氨酸激酶39 / 高血压 / 蒙古族 / 基因-环境交互作用 / 饮茶

Key words

serine threonine kinase 39 / hypertension / Mongolian / gene-environment interaction / tea consumption

引用本文

引用格式 ▾
田英杰,苏日娜,赵兴胜. 蒙古族人群中丝氨酸苏氨酸激酶39(STK39)基因多态性与环境因素交互作用对原发性高血压的影响[J]. 中华高血压杂志(中英文), 2026, 34(7): 677-684 DOI:10.16439/j.issn.1673-7245.2025-0304

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Kario K, Okura A, Hoshide S, et al. The WHO global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy[J]. Hypertens Res, 2024, 47(5): 1099-1102.

[2]

Zhang M, Shi Y, Zhou B, et al. Prevalence, awareness, treatment, and control of hypertension in China, 2004—18: findings from six rounds of a national survey[J]. BMJ, 2023, 380: e071952.

[3]

Yang Y, He K, Zhang Y, et al. Ethnicity disparities in the prevalence, awareness, treatment, and control rates of hypertension in China[J]. Int J Hypertens, 2023, 2023: 1432727.

[4]

Yu P, Ning Y, Gao Y, et al. Hypertension among Mongolian adults in China: a cross—sectional study of prevalence, awareness, treatment, control, and related factors: hypertension among Mongolian adults in China[J]. J Clin Hypertens (Greenwich), 2021, 23(9): 1786-1801.

[5]

Wang Y, O'Connell JR, McArdle PF, et al. From the cover: whole—genome association study identifies STK39 as a hypertension susceptibility gene[J]. Proc Natl Acad Sci U S A, 2009, 106(1): 226-231.

[6]

Persu A, Evenepoel L, Jin Y, et al. STK39 and WNK1 are potential hypertension susceptibility genes in the BELHYPGEN cohort[J]. Medicine (Baltimore), 2016, 95(15): e2968.

[7]

Määttä KM, Nikkari ST, Lähteelä KH, et al. A functional variant in the serine—threonine kinase coding gene is associated with hypertension: a case—control study in a Finnish population, the Tampere adult population cardiovascular risk study[J]. J Hypertens, 2013, 31(3): 516-520.

[8]

Fava C, Danese E, Montagnana M, et al. Serine/threonine kinase 39 is a candidate gene for primary hypertension especially in women: results from two cohort studies in Swedes[J]. J Hypertens, 2011, 29(3): 484-491.

[9]

Sombié HK, Kologo JK, Tchelougou D, et al. Positive association between ATP2B1 rs17249754 and essential hypertension: a case—control study in Burkina Faso, West Africa[J]. BMC Cardiovasc Disord, 2019, 19(1): 155.

[10]

Kidambi S, Ghosh S, Kotchen JM, et al. Non—replication study of a genome—wide association study for hypertension and blood pressure in African Americans[J]. BMC Med Genet, 2012, 13: 27.

[11]

Shin D, Lee S, Park S, et al. Association between serine/threonine kinase 39 gene polymorphism, hypertension, and other cardiovascular risk factors in Koreans[J]. Korean Circ J, 2013, 43(1): 13-22.

[12]

Shi R, Li J, He J, et al. Association of with—no—lysine kinase 1 and serine/threonine kinase 39 gene polymorphisms and haplotypes with essential hypertension in Tibetans[J]. Environ Mol Mutagen, 2018, 59(2): 151-160.

[13]

Zhao H, Qi Y, Wang Y, et al. Interactive contribution of serine/threonine kinase 39 gene multiple polymorphisms to hypertension among Northeastern Han Chinese[J]. Sci Rep, 2014, 4: 5116.

[14]

Chen L, Zhao W, Tian W, et al. STK39 is an independent risk factor for male hypertension in Han Chinese[J]. Int J Cardiol, 2012, 154(2): 122-127.

[15]

Tang L, Wang Y, Bao M, et al. The rs3754777 polymorphism of the STK39 gene is associated with essential hypertension in Central South Chinese Han males[J]. Hypertens Res, 2016, 39(6): 480-481.

[16]

Yang X, Sarengaowa, He G, et al. Genomic insights into the genetic structure and natural selection of Mongolians[J]. Front Genet, 2021, 12: 735786.

[17]

吴广, 田英杰, 迎春, . 内蒙古部分地区蒙古族与汉族居民高血压危险因素的差异性分析[J]. 中国心血管杂志, 2020, 25(4): 361-366.

[18]

中国高血压防治指南修订会 . 中国高血压防治指南 (2018年修订版)[J]. 中国心血管杂志, 2019, 24(1): 24-56.

[19]

田英杰, 吴广, 吴云, . 三酰甘油—葡萄糖乘积指数与肥胖对蒙古族高血压患病的交互作用[J]. 中华高血压杂志, 2023, 31(1): 78-84.

[20]

国家卫生健康委员会肥胖症诊疗指南编写委员会 . 肥胖症诊疗指南 (2024年版)[J]. 中国循环杂志, 2025, 40(1): 6-30.

[21]

El Achhab Y, Nazek L, Maalej M, et al. Prevalence, control and risk factors related to hypertension among Moroccan adults: a multicentre study[J]. East Mediterr Health J, 2019, 25(7): 447-456.

[22]

中华医学会内分泌学分会 . 中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志, 2020, 36(1): 1-13.

[23]

Pan X, Wang L, Pan A . Epidemiology and determinants of obesity in China[J]. Lancet Diabetes Endocrinol, 2021, 9(6): 373-392.

[24]

Li HR, Liu QB, Wang WY, et al. Fluoride in drinking water, brick tea infusion and human urine in two counties in Inner Mongolia, China[J]. J Hazard Mater, 2009, 167(1/3): 892-895.

[25]

张颖, 于燕妮, 范彬 . Wnt信号通路在氟中毒肾脏中表达及其意义[J]. 中国公共卫生, 2015, 31(5): 590-593.

[26]

Chen P, Wang Y, Chen F, et al. Epigenetics in obesity: mechanisms and advances in therapies based on natural products[J]. Pharmacol Res Perspect, 2024, 12(1): e1171.

[27]

Yan Z, Zhong Y, Duan Y, et al. Antioxidant mechanism of tea polyphenols and its impact on health benefits[J]. Anim Nutr, 2020, 6(2): 115-123.

基金资助

内蒙古自然科学基金(2024QN08076)

内蒙古人民医院公立医院科研联合基金(2023GLLH0058)

AI Summary AI Mindmap
PDF (818KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/